Increased mutability of Pseudomonas aeruginosa in biofilms.

OBJECTIVES Isolates of Pseudomonas aeruginosa from cystic fibrosis (CF) patients are frequently hypermutable due to selection of mutants with defects in DNA repair genes such as mutS. Since P. aeruginosa grows as a biofilm within the infected CF lung, it is possible that this mode of growth enhances the mutability of the organism thereby increasing the opportunity to derive permanent hypermutators through mutation in DNA repair genes. We have now conducted experiments to examine this possibility. METHODS Using established procedures, we examined the mutability of P. aeruginosa PA01 in planktonic cultures and in biofilm cultures generated by growth in a Sorbarod system. Transcriptional profiling by DNA microarray was used to compare gene expression in planktonic and biofilm cells. RESULTS Mutation frequency determinations for resistance to rifampicin and ciprofloxacin demonstrated that biofilm cultures of P. aeruginosa displayed up to a 105-fold increase in mutability compared with planktonic cultures. Several genes (ahpC, katA, sodB and PA3529, a probable peroxidase) that encode enzymes conferring protection against oxidative DNA damage were down-regulated in biofilm cells. In particular, katA, which encodes the major pseudomonal antioxidant catalase, was down-regulated 7.7-fold. CONCLUSIONS Down-regulation of antioxidant enzymes in P. aeruginosa biofilms may enhance the rate of mutagenic events due to the accumulation of DNA damage. Since P. aeruginosa forms biofilms in the CF lung, this mode of growth may enhance the direct selection of antibiotic-resistant organisms in CF patients and also increase the opportunity to derive permanent hypermutators thereby providing a further source of antibiotic-resistant mutants in the CF lung.

[1]  M. Radman,et al.  Spontaneous and UV-induced mutations in Escherichia coli K-12 strains with altered or absent DNA polymerase I , 1989, Journal of bacteriology.

[2]  F. Kelly,et al.  Evidence for Increased oxidative Damage in Patients with Cystic Fibrosis , 1994, Pediatric Research.

[3]  M. R. Brown,et al.  A simple in vitro model for growth control of bacterial biofilms. , 1995, The Journal of applied bacteriology.

[4]  J. Miller,et al.  Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair. , 1996, Annual review of microbiology.

[5]  Nihon Hassei Seibutsu Gakkai,et al.  Genes to cells , 1996 .

[6]  J. Struthers,et al.  The use of Sorbarod biofilms to study the antimicrobial susceptibility of a strain of Streptococcus pneumoniae. , 1997, The Journal of antimicrobial chemotherapy.

[7]  M. Marinus,et al.  Escherichia coli mutator genes. , 1999, Trends in microbiology.

[8]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[9]  P. Stewart,et al.  Protective Role of Catalase in Pseudomonas aeruginosa Biofilm Resistance to Hydrogen Peroxide , 1999, Applied and Environmental Microbiology.

[10]  D. Hassett,et al.  Role of the Pseudomonas aeruginosa oxyR-recG Operon in Oxidative Stress Defense and DNA Repair: OxyR-Dependent Regulation of katB-ankB, ahpB, andahpC-ahpF , 2000, Journal of bacteriology.

[11]  M. Sasaki,et al.  Genetic analysis of Bacillus subtilis mutator genes. , 2000, The Journal of general and applied microbiology.

[12]  S. Lory,et al.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.

[13]  F. Baquero,et al.  Mutation Frequencies and Antibiotic Resistance , 2000, Antimicrobial Agents and Chemotherapy.

[14]  A. Oliver,et al.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2000, Science.

[15]  Roger E. Bumgarner,et al.  Gene expression in Pseudomonas aeruginosa biofilms , 2001, Nature.

[16]  A. Oliver,et al.  Characterization of the GO system of Pseudomonas aeruginosa. , 2002, FEMS microbiology letters.

[17]  M. Vasil,et al.  GeneChip® expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis genes , 2002, Molecular microbiology.

[18]  R. Finch,et al.  An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. , 2002, The Journal of antimicrobial chemotherapy.

[19]  I. Chopra,et al.  The role of mutators in the emergence of antibiotic-resistant bacteria. , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[20]  A. Oliver,et al.  Lack of Association between Hypermutation and Antibiotic Resistance Development in Pseudomonas aeruginosa Isolates from Intensive Care Unit Patients , 2004, Antimicrobial Agents and Chemotherapy.

[21]  Martin Schuster,et al.  Pseudomonas aeruginosa Biofilms Exposed to Imipenem Exhibit Changes in Global Gene Expression and β-Lactamase and Alginate Production , 2004, Antimicrobial Agents and Chemotherapy.

[22]  You-Hee Cho,et al.  KatA, the Major Catalase, Is Critical for Osmoprotection and Virulence in Pseudomonas aeruginosa PA14 , 2005, Infection and Immunity.

[23]  N. Høiby,et al.  Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation , 2005, Antimicrobial Agents and Chemotherapy.

[24]  A. Paccanaro,et al.  Clustering of Pseudomonas aeruginosa transcriptomes from planktonic cultures, developing and mature biofilms reveals distinct expression profiles , 2006, BMC Genomics.

[25]  H. Maki,et al.  Impact of reactive oxygen species on spontaneous mutagenesis in Escherichia coli , 2006, Genes to cells : devoted to molecular & cellular mechanisms.